Compare Hecla Mining Company Common Stock (HL) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hecla Mining Company Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Hecla Mining Company Common Stock trades at $17.17 (market cap $11.24B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.46 (market cap $6.04B). The key difference: Hecla Mining Company Common Stock is the larger of the two by market cap, and Hecla Mining Company Common Stock pays a 0.09% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hecla Mining Company Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| HL | IOVA | |
|---|---|---|
Market Cap | $11.24B | $6.04B |
Volume | 37,227,749 | 14,805,993 |
Sector | Basic Materials | Health |
52-Week High | $31.81 | $14.82 |
52-Week Low | $11.97 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.77B | $5.97B |
Dividend Yield | 0.09% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hecla Mining Company Common Stock
Hecla Mining is a precious metals producer focused on silver and gold. It operates mines in the United States and Canada.
Read more on HL →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
